Published in Women's Health Weekly, December 11th, 2003
"Human papillomavirus (HPV) seroprevalence and determinants of seropositivity were assessed in a 10049 female cohort in Guanacaste, Costa Rica. Serologic responses based on VLP-based ELISA were obtained from the plasma collected at study enrollment in 1993/1994 for HPV-16 (n=9949), HPV-18 (n=9928), HPV-31 (n=9932), and HPV-45 (n=3019). Seropositivity was defined as 5 standard deviations above the mean optical density obtained for studied virgins (n=573)," scientists in the United States report.
"HPVs 16, 18,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly